MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Common Genotypes Of Dystonia and Response To DBS; Tertiary Center Experience

A. Aldakheel, H. Alhodaif, Y. Alkhodair, H. Alfaris (Riaydh, Saudi Arabia)

Meeting: 2024 International Congress

Abstract Number: 1413

Keywords: Deep brain stimulation (DBS), Dystonia: Genetics

Category: Dystonia: Epidemiology, Genetics, Phenomenology

Objective: This study aims to evaluate the impact of deep brain stimulation (DBS) on monogenic dystonia.

Background: Monogenic dystonia is a heterogenic group of disorders with variability in clinical presentation and response to treatment. Surgical treatment for dystonia has dramatically expanded over the past several decades. With the evolution of genetic testing, prediction of clinical outcomes following the DBS can be made in certain types of monogenic dystonia.

Method: This is a retrospective study of patients with monogenic dystonia who underwent DBS after failing appropriate dystonia-specific medication. It details their genetic testing, clinical assessment pre- and post-DBS placement, neuroradiological features, and standardized dystonia scales.

Results: The study included a total of eleven patients (six females) with confirmed genetic dystonia who underwent DBS after failure of medical therapy. Genetic testing revealed the following genotypes: DYT1 (TOR1A) in six patients, DYT6 (THAP1) in four patients, and DYT11 (SGCE) in one patient. DBS targeting the globus pallidus internus (GPi) in 10/11 patients, and one patient received DBS targeting the subthalamic nucleus (STN). The mean duration between dystonia onset and DBS was five years. Improvement in dystonic symptoms after DBS placement was noted in all 11 patients, as noted by clinical improvement and dystonia-specific scale. However, two patients with DYT1 showed worsening of their dystonia early in the disease course due to the progression of lower limb bony deformities in one patient and lead migration secondary to significant weight loss in the second patient. The mean follow-up period was 7.5 years, with the most prolonged follow-up period being 22 years.

Conclusion: Monogenic dystonia is a progressive disease, though early DBS placement elevates the disease symptoms. DBS targeting either the GPi or STN has a positive impact. Early referral and evaluation for DBS placement should be to improve patient symptoms and quality of life.

To cite this abstract in AMA style:

A. Aldakheel, H. Alhodaif, Y. Alkhodair, H. Alfaris. Common Genotypes Of Dystonia and Response To DBS; Tertiary Center Experience [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/common-genotypes-of-dystonia-and-response-to-dbs-tertiary-center-experience/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/common-genotypes-of-dystonia-and-response-to-dbs-tertiary-center-experience/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley